MILFORD, Mass.--(BUSINESS WIRE)--SeraCare Life Sciences, Inc. (NASDAQ:SRLS) today announced that it has received notification from The NASDAQ Stock Market® that its common stock has been approved for relisting on the NASDAQ Capital Market. The Company’s common stock will begin trading today on NASDAQ at market open under the symbol SRLS. SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, validation and production of human diagnostics and therapeutics.
